Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

644 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Carlsson SV, Talala KM, Lilja H, Denis LJ, Recker F, Paez A, Puliti D, Villers A, Rebillard X, Kilpeläinen TP, Stenman UH, Godtman RA, Stinesen Kollberg K, Moss SM, Kujala P, Taari K, Huber A, van der Kwast T, Heijnsdijk EA, Bangma C, De Koning HJ, Schröder FH, Auvinen A; ERSPC investigators. Hugosson J, et al. Among authors: zappa m. Eur Urol. 2019 Jul;76(1):43-51. doi: 10.1016/j.eururo.2019.02.009. Epub 2019 Feb 26. Eur Urol. 2019. PMID: 30824296 Free PMC article. Clinical Trial.
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis.
Paci E, Coviello E, Miccinesi G, Puliti D, Cortesi L, De Lisi V, Ferretti S, Mangone L, Perlangeli V, Ponti A, Ravaioli A, de' Bianchi PS, Segnan N, Stracci F, Tumino R, Zarcone M, Zorzi M, Zappa M; IMPACT Working Group. Paci E, et al. Among authors: zappa m. Eur J Cancer. 2008 Apr;44(6):858-65. doi: 10.1016/j.ejca.2008.02.026. Epub 2008 Mar 21. Eur J Cancer. 2008. PMID: 18359222
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. Among authors: zappa m. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Mammographic screening and breast cancer: Florentine data.
Paci E, Puliti D, Zappa M. Paci E, et al. Among authors: zappa m. Arch Intern Med. 2009 May 25;169(10):997-8. doi: 10.1001/archinternmed.2009.92. Arch Intern Med. 2009. PMID: 19468096 No abstract available.
Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).
Roobol MJ, Kerkhof M, Schröder FH, Cuzick J, Sasieni P, Hakama M, Stenman UH, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis L, Recker F, Berenguer A, Ruutu M, Kujala P, Bangma CH, Aus G, Tammela TL, Villers A, Rebillard X, Moss SM, de Koning HJ, Hugosson J, Auvinen A. Roobol MJ, et al. Among authors: zappa m. Eur Urol. 2009 Oct;56(4):584-91. doi: 10.1016/j.eururo.2009.07.018. Epub 2009 Jul 28. Eur Urol. 2009. PMID: 19660851
More on screening mammography.
Puliti D, Miccinesi G, Zappa M. Puliti D, et al. Among authors: zappa m. N Engl J Med. 2011 Jan 20;364(3):284-5; author reply 286. doi: 10.1056/NEJMc1011881. N Engl J Med. 2011. PMID: 21247319 No abstract available.
Towards an optimal interval for prostate cancer screening.
van Leeuwen PJ, Roobol MJ, Kranse R, Zappa M, Carlsson S, Bul M, Zhu X, Bangma CH, Schröder FH, Hugosson J. van Leeuwen PJ, et al. Among authors: zappa m. Eur Urol. 2012 Jan;61(1):171-6. doi: 10.1016/j.eururo.2011.08.002. Epub 2011 Aug 10. Eur Urol. 2012. PMID: 21840117 Clinical Trial.
644 results